Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells
- PMID: 9688631
- DOI: 10.1152/ajpendo.1998.275.2.E285
Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells
Abstract
The purpose of this study was to determine whether the antiobesity actions of dehydroepiandrosterone (DHEA) are due to an influence on preadipocyte proliferation and/or differentiation in primary cultures of pig and rat stromal-vascular (SV) cells. Pig SV cells were isolated from dorsal subcutaneous adipose tissue of 7-day-old pigs. For the proliferation assays, pig SV cells were grown for 4 days in plating medium containing DHEA at 0, 15, 50, or 150 microM. For the differentiation assays, pig SV cells were grown in plating medium for 3 days and then switched to a serum-free medium containing DHEA at 0, 15, 50, or 150 microM for the next 6 days. Rat SV cells were isolated from inguinal fat pads of 5-wk-old male rats. Rat SV cells were exposed to DHEA at 0, 5, 25, or 75 microM during proliferation. For the differentiation assays, rat SV cells were grown for 8 days in a serum-free medium containing DHEA at 0, 5, 25, or 75 microM. Preadipocyte differentiation [lipid staining, glycerol-3-phosphate dehydrogenase (GPDH) activity] and proliferation (preadipocyte-specific antigen staining) decreased with increasing levels of DHEA in cultures of pig SV cells. In cultures of rat SV cells, preadipocyte differentiation (lipid staining, GPDH activity) and proliferation ([3H]thymidine incorporation) were decreased in the 25 and 75 microM DHEA groups compared with the control and 5 microM DHEA groups. The level of expression of CCAAT enhancer binding protein-alpha, a master regulator of adipogenesis, in cultures of pig SV cells treated with 150 microM DHEA was 38% of control cultures. These data support the hypothesis that DHEA directly attenuates adipogenesis via attenuation of preadipocyte proliferation and differentiation.
Similar articles
-
Dehydroepiandrosterone alters the growth of stromal vascular cells from human adipose tissue.Int J Obes Relat Metab Disord. 1999 Jun;23(6):595-602. doi: 10.1038/sj.ijo.0800874. Int J Obes Relat Metab Disord. 1999. PMID: 10411232
-
Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes.Biochem Biophys Res Commun. 1998 Jul 30;248(3):497-504. doi: 10.1006/bbrc.1998.8996. Biochem Biophys Res Commun. 1998. PMID: 9703954
-
Recruitment and differentiation of intramuscular preadipocytes in stromal-vascular cell cultures derived from neonatal pig semitendinosus muscles.J Anim Sci. 2004 Feb;82(2):429-37. doi: 10.2527/2004.822429x. J Anim Sci. 2004. PMID: 14974540
-
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.Adv Enzyme Regul. 1987;26:355-82. doi: 10.1016/0065-2571(87)90023-9. Adv Enzyme Regul. 1987. PMID: 2960133 Review.
-
Preadipocyte and adipose tissue differentiation in meat animals: influence of species and anatomical location.Annu Rev Anim Biosci. 2014 Feb;2:323-51. doi: 10.1146/annurev-animal-022513-114211. Annu Rev Anim Biosci. 2014. PMID: 25384146 Review.
Cited by
-
Adipogenesis.Cold Spring Harb Perspect Biol. 2012 Sep 1;4(9):a008417. doi: 10.1101/cshperspect.a008417. Cold Spring Harb Perspect Biol. 2012. PMID: 22952395 Free PMC article. Review.
-
Dehydroepiandrosterone and human adipose tissue.J Endocrinol Invest. 2006 May;29(5):393-8. doi: 10.1007/BF03344121. J Endocrinol Invest. 2006. PMID: 16794361
-
Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate.Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):2007-12. doi: 10.1073/pnas.0610898104. Epub 2007 Jan 30. Proc Natl Acad Sci U S A. 2007. PMID: 17264205 Free PMC article.
-
Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway.Mol Cell Biochem. 2011 Sep;355(1-2):127-34. doi: 10.1007/s11010-011-0846-x. Epub 2011 May 1. Mol Cell Biochem. 2011. PMID: 21533767
-
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.Int J Endocrinol. 2018 Jul 25;2018:1349868. doi: 10.1155/2018/1349868. eCollection 2018. Int J Endocrinol. 2018. PMID: 30147722 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources